Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease
Authors not listed
Central Hospital, Nancy, France · 2024
Abstract
Alzheimer's disease (AD) is the leading cause of dementia in France. It is a multifactorial pathology, combining genetic and environmental risk factors. Homocysteine, a sulfur-containing amino acid belonging to the methionine-monocarbon cycle, has frequently been found at high levels in neurodegenerative diseases, and in AD in particular. It has been shown on human brain sections that the interaction of homocysteine with tau and MAP1, two key AD proteins, was significantly higher in AD patients than in controls, and corresponded to an N-homocysteinylation type interaction.
This is a prospective study, the main objective of which is to compare MAP1 N-homocysteinylation levels in fibroblasts from individuals with AD versus disease-free cell lines.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2024). Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease. <em>Central Hospital, Nancy, France</em>. https://clinicaltrials.gov/study/NCT06168955
Vancouver
Anonymous. Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease. Central Hospital, Nancy, France. 2024.
BibTeX
@misc{anon2024Studyo,
title = {Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease},
author = {Anonymous},
journal = {Central Hospital, Nancy, France},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Synapse 2017
Citation only
Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration
Neurobiology of Disease 2005
Citation only
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach
Oxidative Medicine and Cellular Longevity 2018
Open access · CC-BY
Age‐Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
PubMed 2009
Preprint
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Diabetes Care 2004
Citation only
Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?
Octapharma 2009
Open access · US-GOV